J Am Soc Nephrol. 2012 Apr 19.
Protein Kinase G Inhibits Flow-Induced Ca2+ Entry into Collecting Duct Cells.
Du, J., Wong, W. Y., Sun, L., Huang, Y., Yao, X.,
["*School of Biomedical Sciences and."]
["*School of Biomedical Sciences and."]
The renal cortical collecting duct (CCD) contributes to the maintenance of K(+) homeostasis by modulating renal K(+) secretion. Cytosolic Ca(2+) ([Ca(2+)](i)) mediates flow-induced K(+) secretion in the CCD, but the mechanisms regulating flow-induced Ca(2+) entry into renal epithelial cells are not well understood. Here, we found that atrial natriuretic peptide, nitric oxide, and cyclic guanosine monophosphate (cGMP) act through protein kinase G (PKG) to inhibit flow-induced increases in [Ca(2+)](i) in M1-CCD cells. Coimmunoprecipitation, double immunostaining, and functional studies identified heteromeric TRPV4-P2 channels as the mediators of flow-induced Ca(2+) entry into M1-CCD cells and HEK293 cells that were coexpressed with both TRPV4 and TRPP2. In these HEK293 cells, introducing point mutations at two putative PKG phosphorylation sites on TRPP2 abolished the ability of cGMP to inhibit flow-induced Ca(2+) entry. In addition, treating M1-CCD cells with fusion peptides that compete with the endogenous PKG phosphorylation sites on TRPP2 also abolished the cGMP-mediated inhibition of the flow-induced Ca(2+) entry. Taken together, these data suggest that heteromeric TRPV4-P2 channels mediate the flow-induced entry of Ca(2+) into collecting duct cells. Furthermore, substances such as atrial natriuretic peptide and nitric oxide, which increase cGMP, abrogate flow-induced Ca(2+) entry through PKG-mediated inhibition of these channels.
PMID: 22518003
Screening
Validation: In vitro validation
Validation: In vivo validation
Characterization
Functional consequence
|
top
|
Validation: In vivo validation
|
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Assay with endogenous proteins | Assay with overexpressed proteins | Reference | ||||||||
| Cell or tissue | Cell or tissue | TRP channel construct | Interactor construct | |||||||
| TRP channel | Interactor | Method | Species | Region | Species | Region | ||||
| TRPV4 |
|
TRPP1 | Co-immunoprecipitation | HEK293 | Mouse | Full-length | Human | Full-length | 22518003 | |
| TRPV4 |
|
TRPP1 | Co-immunoprecipitation | CRL-2038 (Mouse renal cortical collecting duct cell line / M1-CCD) | Mouse | Full-length | Human | Full-length | 22518003 | |
| TRPV4 |
|
TRPP1 | Co-immunofluorescence staining | HEK293 | Mouse | Full-length | Human | Full-length | 22518003 | |
| TRPV4 |
|
TRPP1 | Co-immunofluorescence staining | CRL-2038 (Mouse renal cortical collecting duct cell line / M1-CCD) | Mouse | Full-length | Human | Full-length | 22518003 | |
(
:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)
:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)
Screening
Validation: In vitro validation
Validation: In vivo validation
Characterization
Functional consequence
|
top
|
Functional consequence
|
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TRP channel | Interactor | Method | Post-translational modification | Subcellular trafficking | Activity | Reference | ||||||
| TRPV4 |
|
TRPP1 | Calcium measurement | New channel creation | 22518003 | |||||||
(
:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)
:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)



Screening
